Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1063828

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the statement on page 72 of the Independent Cancer Taskforce's Cancer Strategy for 2015-2020 that all NHS trusts should now be recording recurrent and secondary breast cancer patients, how many and what proportion of NHS trusts are undertaking such recording.
	tabling member constituency	Oldham East and Saddleworth
	tabling member printed	Debbie Abrahams
	uin	222763
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The NHS Cancer Programme aims to improve access to cancer Clinical Nurse Specialists (CNS) for all cancer patients when they need it, including those with secondary breast cancer. Health Education England is also working to expand the number of CNS and develop clear CNS competencies and routes into training.</p><p>The National Cancer Registration and Analysis Service (NCRAS) has mandated collection of breast cancer recurrence data in its Cancer Services and Outcomes Dataset (COSD) since 2013. Hospital trusts are also required to submit recurrence data in the Cancer Waiting Times (CWT) dataset. Data published on the NCRAS legacy website shows that of the 140 trusts that could be expected to be collecting data on breast cancer recurrence in 2016, 140 submitted data for 2016 diagnoses through the COSD or CWT data collection mechanisms. The NCRAS legacy website is available at the following link:</p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222762 question first answered 21/02/2019 14:58:17 answering member 4067 label Biography information for Steve Brine
	tabling member	4212 label Biography information for Debbie Abrahams

1063789

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Human Medicines (Amendment) Regulations 2019, what process will be followed to consult with relevant health care professionals in the development of advice contained in a Serious Shortage Protocol.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	222724
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222720 222723 222725 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

1063790

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Human Medicines (Amendment) Regulations 2019, what methods the Government plans to use to whether a Serious Shortage Protocol is necessary; what information such a decision would be based on; what level of consultation with medical experts the Government plans to seek on such protocols; and how the Government plans to engage in such consultation.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	222725
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222720 222723 222724 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

1063651

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	GP at Hand: Birmingham
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether patients in Birmingham that sign up to the Babylon GP at Hand application are recorded as a patient of Hammersmith and Fulham CCG in London.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	222638
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>NHS England has considered the expansion of the service to Birmingham following initial concerns, in particular regarding access to immunisation and screening programmes for Babylon GP at Hand patients, and a solution has been identified. NHS England will now work together with NHS Hammersmith and Fulham and Birmingham and Solihull Clinical Commissioning Groups (CCGs), national screening services, and Babylon GP at Hand to mobilise the service and agree a start date.</p><p>General practice payments are made to practices according to their registered patient list size, so the funding for general practice care will follow the patients. NHS England will shortly engage on changes to out of area registration rules, some of the current payments to primary care providers and the mechanisms by which new providers can enter the market.</p><p>The new General Practitioner Contract Framework made two changes to the current payment system:</p><p>- the rurality index payment will be amended to apply to patients living within a practice catchment area only, rather than to all patients. This is to better reflect costs; and</p><p>- the London adjustment will be amended to apply to patients resident in London, rather than registered with a London-based practice</p><p> </p><p>CCG allocations have been revised for 2019/20. Hammersmith and Fulham CCG’s allocation takes account of the increased list size of the GP at Hand practice, with the CCG’s funding growth determined by an assessment of the CCG’s fair share of overall funding and rules on the pace of change in funding allocations.</p><p> </p><p>All patients registered with the Babylon GP at Hand practice are recorded as patients of Hammersmith and Fulham CCG.</p><p> </p><p>Hammersmith and Fulham CCG have commissioned an independent evaluation of the Babylon GP at Hand practice. This will look at the impact of the service on patient experience, primary care workforce, use of other services, such as accident and emergency departments and walk-in centres, and system value.</p><p> </p><p>Babylon GP at Hand will provide physical premises in both London and Birmingham for those patients who require a face-to-face consultation. Under the current GP of Choice Policy, the CCGs where ‘out of area’ patients live are required to ensure out of hours care and home visits can be accessed by those patients in their resident area if they need it.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222634 222635 222637 222639 222640 question first answered 21/02/2019 16:24:57 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

1063648

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	GP at Hand: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether funding allocated to patients that sign up to the Babylon GP at Hand application is transferred to the Hammersmith and Fulham Care Commissioning Group where the application is hosted.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	222635
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>NHS England has considered the expansion of the service to Birmingham following initial concerns, in particular regarding access to immunisation and screening programmes for Babylon GP at Hand patients, and a solution has been identified. NHS England will now work together with NHS Hammersmith and Fulham and Birmingham and Solihull Clinical Commissioning Groups (CCGs), national screening services, and Babylon GP at Hand to mobilise the service and agree a start date.</p><p>General practice payments are made to practices according to their registered patient list size, so the funding for general practice care will follow the patients. NHS England will shortly engage on changes to out of area registration rules, some of the current payments to primary care providers and the mechanisms by which new providers can enter the market.</p><p>The new General Practitioner Contract Framework made two changes to the current payment system:</p><p>- the rurality index payment will be amended to apply to patients living within a practice catchment area only, rather than to all patients. This is to better reflect costs; and</p><p>- the London adjustment will be amended to apply to patients resident in London, rather than registered with a London-based practice</p><p> </p><p>CCG allocations have been revised for 2019/20. Hammersmith and Fulham CCG’s allocation takes account of the increased list size of the GP at Hand practice, with the CCG’s funding growth determined by an assessment of the CCG’s fair share of overall funding and rules on the pace of change in funding allocations.</p><p> </p><p>All patients registered with the Babylon GP at Hand practice are recorded as patients of Hammersmith and Fulham CCG.</p><p> </p><p>Hammersmith and Fulham CCG have commissioned an independent evaluation of the Babylon GP at Hand practice. This will look at the impact of the service on patient experience, primary care workforce, use of other services, such as accident and emergency departments and walk-in centres, and system value.</p><p> </p><p>Babylon GP at Hand will provide physical premises in both London and Birmingham for those patients who require a face-to-face consultation. Under the current GP of Choice Policy, the CCGs where ‘out of area’ patients live are required to ensure out of hours care and home visits can be accessed by those patients in their resident area if they need it.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222634 222637 222638 222639 222640 question first answered 21/02/2019 16:24:57 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

1063653

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	GP at Hand
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what safeguards his Department has put in place to ensure that patients that have signed up to Babylon GP at Hand application maintain access to a local GP practice in the event that they need to see a GP face-to-face.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	222640
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>NHS England has considered the expansion of the service to Birmingham following initial concerns, in particular regarding access to immunisation and screening programmes for Babylon GP at Hand patients, and a solution has been identified. NHS England will now work together with NHS Hammersmith and Fulham and Birmingham and Solihull Clinical Commissioning Groups (CCGs), national screening services, and Babylon GP at Hand to mobilise the service and agree a start date.</p><p>General practice payments are made to practices according to their registered patient list size, so the funding for general practice care will follow the patients. NHS England will shortly engage on changes to out of area registration rules, some of the current payments to primary care providers and the mechanisms by which new providers can enter the market.</p><p>The new General Practitioner Contract Framework made two changes to the current payment system:</p><p>- the rurality index payment will be amended to apply to patients living within a practice catchment area only, rather than to all patients. This is to better reflect costs; and</p><p>- the London adjustment will be amended to apply to patients resident in London, rather than registered with a London-based practice</p><p> </p><p>CCG allocations have been revised for 2019/20. Hammersmith and Fulham CCG’s allocation takes account of the increased list size of the GP at Hand practice, with the CCG’s funding growth determined by an assessment of the CCG’s fair share of overall funding and rules on the pace of change in funding allocations.</p><p> </p><p>All patients registered with the Babylon GP at Hand practice are recorded as patients of Hammersmith and Fulham CCG.</p><p> </p><p>Hammersmith and Fulham CCG have commissioned an independent evaluation of the Babylon GP at Hand practice. This will look at the impact of the service on patient experience, primary care workforce, use of other services, such as accident and emergency departments and walk-in centres, and system value.</p><p> </p><p>Babylon GP at Hand will provide physical premises in both London and Birmingham for those patients who require a face-to-face consultation. Under the current GP of Choice Policy, the CCGs where ‘out of area’ patients live are required to ensure out of hours care and home visits can be accessed by those patients in their resident area if they need it.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222634 222635 222637 222638 222639 question first answered 21/02/2019 16:24:57 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

1063806

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Cumbria
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of provision of NHS dentistry for adults in Cumbria.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	222741
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>NHS England is responsible on behalf of the Secretary of State for Health and Social Care for commissioning dental services to meet local need and assessing the level of that need. NHS England advises that it is aware of and taking action to address identified shortfalls in dental provision particularly, but not exclusively, in South Cumbria. Action taken already in South Cumbria has included offering practices additional funding to take on additional patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/02/2019 16:12:25 answering member 4067 label Biography information for Steve Brine
	tabling member	1591 label Biography information for Tim Farron

1063626

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tuberculosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what level of uptake has been achieved by the new entrant latent TB testing and treatment programme; b) what plans have been put in place to (a) increase uptake, (b) reduce variance between local authority areas and (c) share best practice and whether the programme is on target to accrue the savings to the public purse described in the Collaborative TB Strategy for England.
	tabling member constituency	Ealing, Southall
	tabling member printed	Mr Virendra Sharma
	uin	222613
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>Test uptake among the eligible invited population in 2017 ranged between 19.4% and 82.4% depending on clinical commissioning group (CCG) area.</p><p> </p><p>In 2017, 27 CCGs reported treatment data; for the 1,364 people who tested positive for latent tuberculosis infection (LTBI) in these areas, 60.3% accessed treatment. Overall treatment completion among this group stood at 71.0% in 2017.</p><p> </p><p>NHS England has invited CCGs with high incidence of tuberculosis (TB) to submit plans on how they will locally increase uptake of testing and treatment for LTBI, with the ability to access NHS England funding to support implementation of their plans. £35 million has been made available to support this work over the past four years. NHS England supports CCGs to develop local plans for increasing uptake of LTBI testing, including sharing best practice. This contributes to reducing variation between local authority areas.</p><p> </p><p>Modelling undertaken as part of the five-year TB strategy indicated that return on investment should begin to be recovered from year five onwards, with net savings at year 10 and beyond.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/02/2019 15:03:47 answering member 4067 label Biography information for Steve Brine
	tabling member	1604 label Biography information for Mr Virendra Sharma

1063785

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what definition will be used by the Government to determine a serious shortage of a medicine that will be used to trigger a Serious Shortage Protocol for a medicine under the Human Medicines (Amendment) Regulations 2019.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	222720
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222723 222724 222725 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

1063788

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what data source will be used to monitor stocks and availability of medicines in order to determine the need for a Serious Shortage Protocol under the Human Medicines (Amendment) Regulations 2019.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	222723
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222720 222724 222725 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott